What is the impact of losartan therapy (focusing on the drug's blood pressure-lowering effect only) on 10-year stroke risk, as calculated from the Framingham Stroke Risk Score, in these patients?

Welcome to a transformative healthcare experience where acquiring Losartan online is not just a transaction but a commitment to your well-being. Our platform redefines the way you access this ...

Qualifying patients (n=51) were allocated to placebo, 25 or 100 mg losartan, or 20 mg enalapril. Blood pressure, plasma drug concentrations, and renin-angiotensin-aldosterone system mediators were ...

Find all the commercial and brand names of generic drug called Losartan. This is an invaluable reference resource for healthcare professionals, patients, caregivers and anyone in need of ...

The central repository of the drug and medication centre helps to navigate to different sections. Medindia's platform provides carefully curated details on generics, brand names, side-effects ...

This is a multicenter randomized controlled trial comparing losartan vs placebo for outpatients with COVID. Every patient that is tested in the ED and drive through clinic will receive a brochure with ...

In contrast to irbesartan which had no effect on SUA, losartan (50 mg od) decreased SUA significantly from 538 ± 26 μmol/L to 491 ± 20 μmol/L (p < 0.01) and to 484 ± 25 μmol/L at 50 mg bid. During the ...

Spontaneous rectus sheath haematomas and cough secondary to losartan are individually rare conditions. Abdominal wall haematomas present with abdominal pain and abdominal mass. Most patients are ...

Losartan+Hydrochlorothiazide is a combination of two medicines. It helps to control high blood pressure in different ways. If high blood pressure is not treated it can lead to heart attacks ...

This study demonstrates that candesartan had greater efficacy in lowering arterial pressure when compared to losartan. Moreover, the duration of effect and response/control rates were ...

Objective: To assess the effect of a combination treatment using anti-hyperuricaemic agents with fenofibrate and/or losartan on uric acid metabolism in hypertriglyceridaemic and/or hypertensive ...